Vertex Gains as Cystic Fibrosis Combo Eases Breathing

Vertex Pharmaceuticals Inc., maker of the cystic fibrosis drug Kalydeco, rose the most ever after the company said the medicine combined with another eased patients’ breathing in a clinical trial.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.